Abouelasrar Salama S, Gouwy M, Van Damme J, Struyf S (2023) Acute-serum amyloid A and A-SAA-derived peptides as formyl peptide receptor (FPR) 2 ligands. Front Endocrinol (Lausanne) 14:1119227. https://doi.org/10.3389/fendo.2023.1119227

Article  PubMed  Google Scholar 

AlBadri A, Lai K, Wei J, Landes S, Mehta PK, Li Q, Johnson D, Reis SE, Kelsey SF, Bittner V (2017) Inflammatory biomarkers as predictors of heart failure in women without obstructive coronary artery disease: a report from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE). PLoS ONE 12:e0177684. https://doi.org/10.1371/journal.pone.0177684

Article  PubMed  PubMed Central  Google Scholar 

Anderberg RJ, Meek RL, Hudkins KL, Cooney SK, Alpers CE, Leboeuf RC, Tuttle KR (2015) Serum amyloid A and inflammation in diabetic kidney disease and podocytes. Lab Investig 95:697. https://doi.org/10.1038/labinvest.2015.38

Article  PubMed  Google Scholar 

Andreadou I, Ghigo A, Nikolaou P-E, Swirski FK, Thackeray JT, Heusch G, Vilahur G (2025) Immunometabolism in heart failure. Nat Rev Cardiol 22:751–772. https://doi.org/10.1038/s41569-025-01165-8

Article  PubMed  Google Scholar 

Ather JL, Poynter ME (2018) Serum amyloid A3 is required for normal weight and immunometabolic function in mice. PLoS ONE 13:e0192352. https://doi.org/10.1371/journal.pone.0192352

Article  PubMed  PubMed Central  Google Scholar 

Badolato R, Wang JM, Murphy WJ, Lloyd AR, Michiel DF, Bausserman LL, Kelvin DJ, Oppenheim JJ (1994) Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J Exp Med 180:203–209. https://doi.org/10.1084/jem.180.1.203

Article  PubMed  Google Scholar 

Banka C, Yuan T, De Beer M, Kindy M, Curtiss L, De Beer F (1995) Serum amyloid A (SAA): influence on HDL-mediated cellular cholesterol efflux. J Lipid Res 36:1058–1065. https://doi.org/10.1016/S0022-2275(20)39863-1

Article  PubMed  Google Scholar 

Baranova IN, Vishnyakova TG, Bocharov AV, Kurlander R, Chen Z, Kimelman ML, Remaley AT, Csako G, Thomas F, Eggerman TL (2005) Serum amyloid A binding to CLA-1 (CD36 and LIMPII analogous-1) mediates serum amyloid A protein-induced activation of ERK1/2 and p38 mitogen-activated protein kinases. J Biol Chem 280:8031–8040. https://doi.org/10.1074/jbc.M405009200

Article  PubMed  Google Scholar 

Bellofatto IA, Nikolaou PE, Andreadou I, Canepa M, Carbone F, Ghigo A, Heusch G, Kleinbongard P, Maack C, Podesser BK, Stamatelopoulos K, Stellos K, Vilahur G, Montecucco F, Liberale L (2024) Mechanisms of damage and therapies for cardiac amyloidosis: a role for inflammation? Clin Res Cardiol. https://doi.org/10.1007/s00392-024-02522-2

Article  PubMed  Google Scholar 

Benditt E, Meek R (1989) Expression of the third member of the serum amyloid A gene family in mouse adipocytes. J Exp Med 169:1841–1846. https://doi.org/10.1084/jem.169.5.1841

Article  PubMed  Google Scholar 

Bendotti G, Montefusco L, Lunati ME, Usuelli V, Pastore I, Lazzaroni E, Assi E, Seelam AJ, El Essawy B, Jang J, Loretelli C, D’Addio F, Berra C, Ben Nasr M, Zuccotti G, Fiorina P (2022) The anti-inflammatory and immunological properties of GLP-1 receptor agonists. Pharmacol Res 182:106320. https://doi.org/10.1016/j.phrs.2022.106320

Article  PubMed  Google Scholar 

Bonfioli GB, Rodella L, Metra M, Vizzardi E (2025) GLP-1 receptor agonists as promising anti-inflammatory agents in heart failure with preserved ejection fraction. Heart Fail Rev 30:131–136. https://doi.org/10.1007/s10741-024-10450-6

Article  PubMed  Google Scholar 

Borlaug BA, Paulus WJ (2011) Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. Eur Heart J 32:670–679. https://doi.org/10.1093/eurheartj/ehq426

Article  PubMed  Google Scholar 

Cai L, de Beer MC, de Beer FC, van der Westhuyzen DR (2005) Serum amyloid A is a ligand for scavenger receptor class B type I and inhibits high density lipoprotein binding and selective lipid uptake. J Biol Chem 280:2954–2961. https://doi.org/10.1074/jbc.M411555200

Article  PubMed  Google Scholar 

Catalán V, Gómez-Ambrosi J, Ramirez B, Rotellar F, Pastor C, Silva C, Rodríguez A, Gil MJ, Cienfuegos JA, Frühbeck G (2007) Proinflammatory cytokines in obesity: impact of type 2 diabetes mellitus and gastric bypass. Obes Surg 17:1464–1474. https://doi.org/10.1007/s11695-008-9424-z

Article  PubMed  Google Scholar 

Chambers R, Hutton C, Dieppe P, Whicher J (1991) Comparative study of C reactive protein and serum amyloid A protein in experimental inflammation. Ann Rheum Dis 50:677–679. https://doi.org/10.1136/ard.50.10.677

Article  PubMed  PubMed Central  Google Scholar 

Chami B, Barrie N, Cai X, Wang X, Paul M, Morton-Chandra R, Sharland A, Dennis JM, Freedman SB, Witting PK (2015) Serum amyloid A receptor blockade and incorporation into high-density lipoprotein modulates its pro-inflammatory and pro-thrombotic activities on vascular endothelial cells. Int J Mol Sci 16:11101–11124. https://doi.org/10.3390/ijms160511101

Article  PubMed  PubMed Central  Google Scholar 

Chami B, Hossain F, Hambly TW, Cai X, Aran R, Fong G, Vellajo A, Martin NJ, Wang X, Dennis JM (2019) Serum amyloid A stimulates vascular and renal dysfunction in apolipoprotein E-deficient mice fed a normal chow diet. Front Immunol 10:380. https://doi.org/10.3389/fimmu.2019.00380

Article  PubMed  PubMed Central  Google Scholar 

Chang Y, Liu Y, Zou Y, Ye RD (2025) Recent advances in studies of serum amyloid A: implications in inflammation, immunity and tumor metastasis. Int J Mol Sci. https://doi.org/10.3390/ijms26030987

Article  PubMed  PubMed Central  Google Scholar 

Chen H, Tesic M, Nikolic VN, Pavlovic M, Vucic RM, Spasic A, Jovanovic H, Jovanovic I, Town SE, Padula MP (2022) Systemic biomarkers and unique pathways in different phenotypes of heart failure with preserved ejection fraction. Biomolecules 12:1419. https://doi.org/10.3390/biom12101419

Article  PubMed  PubMed Central  Google Scholar 

Chen J, Liu G, Hong Y, Han J, Yang Z, Yang Y, Li H, Wang S, Jue L, Wang Q (2022) Regulation of atherosclerosis by Toll-like receptor 4 induced by serum amyloid 1: a systematic in vitro study. Biomed Res Int 2022:4887593. https://doi.org/10.1155/2022/4887593

Article  PubMed  PubMed Central  Google Scholar 

Cheng N, He R, Tian J, Ye PP, Ye RD (2008) Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A. J Immunol 181:22–26. https://doi.org/10.4049/jimmunol.181.1.22

Article  PubMed  Google Scholar 

Chiba T, Chang MY, Wang S, Wight TN, McMillen TS, Oram JF, Vaisar T, Heinecke JW, De Beer FC, De Beer MC, Chait A (2011) Serum amyloid A facilitates the binding of high-density lipoprotein from mice injected with lipopolysaccharide to vascular proteoglycans. Arterioscler Thromb Vasc Biol 31:1326–1332. https://doi.org/10.1161/atvbaha.111.226159

Article  PubMed  PubMed Central  Google Scholar 

Christenson K, Björkman L, Tängemo C, Bylund J (2008) Serum amyloid A inhibits apoptosis of human neutrophils via a P2X7-sensitive pathway independent of formyl peptide receptor-like 1. J Leukoc Biol 83:139–148. https://doi.org/10.1189/jlb.0507276

Article  PubMed  Google Scholar 

Collier P, Watson CJ, Voon V, Phelan D, Jan A, Mak G, Martos R, Baugh JA, Ledwidge MT, McDonald KM (2011) Can emerging biomarkers of myocardial remodelling identify asymptomatic hypertensive patients at risk for diastolic dysfunction and diastolic heart failure? Eur J Heart Fail 13:1087–1095. https://doi.org/10.1093/eurjhf/hfr079

Article  PubMed  Google Scholar 

Dalla Vestra M, Mussap M, Gallina P, Bruseghin M, Cernigoi AM, Saller A, Plebani M, Fioretto P (2005) Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes. J Am Soc Nephrol 16(1):S78–S82. https://doi.org/10.1681/asn.2004110961

Article  PubMed  Google Scholar 

de Beer MC, de Beer FC, Gerardot CJ, Cecil DR, Webb NR, Goodson ML, Kindy MS (1996) Structure of the mouse Saa4 gene and its linkage to the serum amyloid A gene family. Genomics 34:139–142. https://doi.org/10.1006/geno.1996.0253

Article  PubMed  Google Scholar 

de Beer MC, Yuan T, Kindy MS, Asztalos BF, Roheim PS, de Beer FC (1995) Characterization of constitutive human serum amyloid A protein (SAA4) as an apolipoprotein. J Lipid Res 36:526–534. https://doi.org/10.1016/S0022-2275(20)39886-2

Article  PubMed  Google Scholar 

de Oliveira EM, Ascar TP, Silva JC, Sandri S, Migliorini S, Fock RA, Campa A (2016) Serum amyloid A links endotoxaemia to weight gain and insulin resistance in mice. Diabetologia 59:1760–1768. https://doi.org/10.1007/s00125-016-3970-z

Article